Interplay of inflammatory biomarkers in heart disease patients with depressive symptoms: An update

Treesa P Varghese1, Sharad Chand2, Nila Mary Varghese3

  • 1Associate Professor, Department of Pharmacy Practice, Yenepoya Pharmacy College & Research Centre (Yenepoya deemed to be University), Naringana, Mangalore, Karnataka, India.

PubMed

Insights

Inflammation links heart disease and depression through shared mechanisms like endothelial dysfunction. Inflammatory biomarkers may predict depressive symptoms in cardiac patients.

Area of Science:

  • Cardiovascular Medicine
  • Psychiatry
  • Immunology

Background:

  • Heart disease and depression share pathophysiological links including endothelial dysfunction, Hypothalamic Pituitary Adrenal (HPA) axis dysregulation, and abnormal platelet activity.
  • Low-grade inflammation influences both endothelial dysfunction and HPA axis dysregulation, suggesting a central role in the co-occurrence of these conditions.
  • Inflammation is implicated in atherosclerotic plaque formation, involving intercellular adhesion molecules (ICAMs) and inflammatory markers.

Purpose of the Study:

  • To review the role of inflammatory biomarkers in heart disease and depression.
  • To assess the potential of these biomarkers in predicting depressive symptoms in patients with heart disease.

Main Methods:

  • Literature review focusing on inflammatory mediators.
  • Analysis of the connection between inflammation, endothelial function, HPA axis, and platelet activity.
  • Evaluation of specific inflammatory markers such as soluble ICAM-1, interleukin-6, Tumour Necrosis Factor, and C-reactive protein.

Main Results:

  • Inflammation is a key factor in the pathophysiology linking heart disease and depression.
  • Soluble ICAM-1, interleukin-6, TNF, and CRP are implicated as significant inflammatory markers.
  • These markers are associated with both cardiovascular disease development and depressive symptoms.

Conclusions:

  • Inflammatory biomarkers play a crucial role in the interplay between heart disease and depression.
  • Investigating these biomarkers may offer predictive value for identifying depressive symptoms in cardiac patients.
  • Targeting inflammation could be a therapeutic strategy for managing comorbid heart disease and depression.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
94
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
31
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
161